These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 11705452

  • 1. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
    Martin V, Sawyer N, Stocco R, Unett D, Lerner MR, Abramovitz M, Funk CD.
    Biochem Pharmacol; 2001 Nov 01; 62(9):1193-200. PubMed ID: 11705452
    [Abstract] [Full Text] [Related]

  • 2. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
    Hui Y, Yang G, Galczenski H, Figueroa DJ, Austin CP, Copeland NG, Gilbert DJ, Jenkins NA, Funk CD.
    J Biol Chem; 2001 Dec 14; 276(50):47489-95. PubMed ID: 11591709
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the human cysteinyl leukotriene 2 receptor.
    Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Williams DL, Zeng Z, Liu Q, Ma L, Clements MK, Coulombe N, Liu Y, Austin CP, George SR, O'Neill GP, Metters KM, Lynch KR, Evans JF.
    J Biol Chem; 2000 Sep 29; 275(39):30531-6. PubMed ID: 10851239
    [Abstract] [Full Text] [Related]

  • 4. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
    Maekawa A, Kanaoka Y, Lam BK, Austen KF.
    Proc Natl Acad Sci U S A; 2001 Feb 27; 98(5):2256-61. PubMed ID: 11226226
    [Abstract] [Full Text] [Related]

  • 5. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
    Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, Schmidt DB, Muccitelli RM, Jenkins O, Murdock PR, Herrity NC, Halsey W, Sathe G, Muir AI, Nuthulaganti P, Dytko GM, Buckley PT, Wilson S, Bergsma DJ, Hay DW.
    Mol Pharmacol; 1999 Sep 27; 56(3):657-63. PubMed ID: 10462554
    [Abstract] [Full Text] [Related]

  • 6. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
    Takasaki J, Kamohara M, Matsumoto M, Saito T, Sugimoto T, Ohishi T, Ishii H, Ota T, Nishikawa T, Kawai Y, Masuho Y, Isogai T, Suzuki Y, Sugano S, Furuichi K.
    Biochem Biophys Res Commun; 2000 Aug 02; 274(2):316-22. PubMed ID: 10913337
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
    Nothacker HP, Wang Z, Zhu Y, Reinscheid RK, Lin SH, Civelli O.
    Mol Pharmacol; 2000 Dec 02; 58(6):1601-8. PubMed ID: 11093801
    [Abstract] [Full Text] [Related]

  • 8. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution.
    Ogasawara H, Ishii S, Yokomizo T, Kakinuma T, Komine M, Tamaki K, Shimizu T, Izumi T.
    J Biol Chem; 2002 May 24; 277(21):18763-8. PubMed ID: 11854273
    [Abstract] [Full Text] [Related]

  • 9. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
    Yan D, Stocco R, Sawyer N, Nesheim ME, Abramovitz M, Funk CD.
    Mol Pharmacol; 2011 Feb 24; 79(2):270-8. PubMed ID: 21078884
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L, Norel X, Bäck M, Gascard JP, Dahlén SE, Brink C.
    Br J Pharmacol; 2002 Dec 24; 137(8):1339-45. PubMed ID: 12466244
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the cloned guinea pig leukotriene B4 receptor: comparison to its human orthologue.
    Boie Y, Stocco R, Sawyer N, Greig GM, Kargman S, Slipetz DM, O'Neill GP, Shimizu T, Yokomizo T, Metters KM, Abramovitz M.
    Eur J Pharmacol; 1999 Sep 10; 380(2-3):203-13. PubMed ID: 10513580
    [Abstract] [Full Text] [Related]

  • 12. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
    Bäck M, Kumlin M, Cotgreave IA, Dahlén SE.
    Br J Pharmacol; 2001 Aug 10; 133(7):1134-44. PubMed ID: 11487525
    [Abstract] [Full Text] [Related]

  • 13. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
    Ni NC, Yan D, Ballantyne LL, Barajas-Espinosa A, St Amand T, Pratt DA, Funk CD.
    J Pharmacol Exp Ther; 2011 Dec 10; 339(3):768-78. PubMed ID: 21903747
    [Abstract] [Full Text] [Related]

  • 14. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
    Dupré DJ, Le Gouill C, Gingras D, Rola-Pleszczynski M, Stanková J.
    J Pharmacol Exp Ther; 2004 Apr 10; 309(1):102-8. PubMed ID: 14718577
    [Abstract] [Full Text] [Related]

  • 15. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
    Ravasi S, Capra V, Mezzetti M, Nicosia S, Rovati GE.
    Mol Pharmacol; 2000 Jun 10; 57(6):1182-9. PubMed ID: 10825389
    [Abstract] [Full Text] [Related]

  • 16. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
    Maekawa A, Kanaoka Y, Xing W, Austen KF.
    Proc Natl Acad Sci U S A; 2008 Oct 28; 105(43):16695-700. PubMed ID: 18931305
    [Abstract] [Full Text] [Related]

  • 17. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
    Wang ML, Huang XJ, Fang SH, Yuan YM, Zhang WP, Lu YB, Ding Q, Wei EQ.
    Biochem Biophys Res Commun; 2006 Nov 17; 350(2):399-404. PubMed ID: 17010308
    [Abstract] [Full Text] [Related]

  • 18. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
    Chang BS, Chang JC, Wang YS, Huang SC.
    Neurogastroenterol Motil; 2008 Oct 17; 20(10):1140-6. PubMed ID: 18651869
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
    Wunder F, Tinel H, Kast R, Geerts A, Becker EM, Kolkhof P, Hütter J, Ergüden J, Härter M.
    Br J Pharmacol; 2010 May 17; 160(2):399-409. PubMed ID: 20423349
    [Abstract] [Full Text] [Related]

  • 20. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
    Brochu-Bourque A, Véronneau S, Rola-Pleszczynski M, Stankova J.
    J Pharmacol Exp Ther; 2011 Feb 17; 336(2):431-9. PubMed ID: 20966037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.